ISB News

A Landscape of Pharmacogenomic Interactions in Cancer

The journal Cell published a study today (July 7) about the integrated analysis of drug response in 1,001 cancer cell lines. This study was undertaken by a large international group of researchers including ISB Senior Research Scientist Theo Knijnenburg. The researchers integrated heterogeneous molecular data of 11,215 tumors and 1,001 cell lines in order to study the drug response of these cell lines to 265 anti-cancer drugs. They uncovered numerous oncogenic aberrations that sensitize to an anti-cancer drug. This study is expected to form an important resource to identify therapeutic options for cancer sub-populations.
Read More

Recent Articles

  • Spotlight on ISB Education graphic

    2024-25 School Year ISB Education Highlights

    In the first installment of the 2024-25 academic year roundup, we highlight some of the top projects the ISB Education team is working on. In October, we welcomed new team members, developed a new format for our popular “Systems Are Everywhere!” workshop, and more.

  • 2024 ISB Virtual Microbiome Series

    Our multi-day microbiome-themed virtual course and symposium is back for the fifth year! ISB is hosting a two-day course on October 16 & 17, 2024, followed by a symposium on October 18, 2024 titled, “A gut feeling: Microbes and their impacts on our minds.” Both events are virtual and free.

  • Fluidized bed reactor

    How Microbes Evolve to Spatially Divide and Conquer an Environment 

    ISB researchers examined representative organisms of two classes of microbes whose interaction contributes to the conversion of more than 1 gigaton of carbon into methane every year. They found that gene mutations selected over a relatively short timeframe in the two microbes led to distinct functions.